Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Doctors initially feared cancer, but Marcondes was ultimately diagnosed with gigantomastia, a rare condition where the breasts grow excessively and uncontrollably, according to the Cleveland Clinic.